Physician profile
Hannah E Warner
NPI 1386169308
$2,896.89
in general payments reported to CMS, 2019-2025
24 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $417 · 2022: $682 · 2023: $763 · 2024: $515 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $514.69 | 2021-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $333.66 | 2021-2025 | |
| Amgen INC. | $290.14 | 2022-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $276.49 | 2021-2024 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.70 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Janssen Pharmaceuticals, INC | $169.06 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $132.64 | 2022-2025 | Airsupra, Farxiga, Breztri |
| E.R. Squibb & Sons, L.L.C. | $123.14 | 2022-2024 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $122.47 | 2022-2025 | |
| Exact Sciences Corporation | $89.49 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $82.97 | 2021-2023 | |
| Pfizer INC. | $81.98 | 2021-2023 | |
| Amarin Pharma, INC. | $60.55 | 2021 | |
| Glaxosmithkline, LLC. | $53.63 | 2021-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbott Laboratories | $48.82 | 2022-2024 | Freestyle Libre 3 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $42.46 | 2021-2022 | |
| Eisai INC. | $36.58 | 2021 | |
| Dexcom, INC. | $34.42 | 2023-2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $30.19 | 2024 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.49 | 2023-2024 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $29.35 | 2021-2022 | |
| Axsome Therapeutics, INC. | $24.71 | 2025 | Auvelity |
| Medtronic, INC. | $23.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.